Lawrence General Hospital offers a comfortable and extensive sleep study that will enable doctors to diagnose potential problems and begin treatment.Accommodations at the new sleep center, which opened last month, feature a private room with a full-sized bed covered in fine linens, a flat screen satellite TV, a modern art picture on the wall and soft lighting. Hospital administrators hope the new center will raise public awareness in the Merrimack Valley about sleep disorders, which have been linked to several serious health problems, including diabetes, high blood pressure and congestive heart failure.
Health officials estimate that up to 70 million Americans suffer from sleep disorders like insomnia, sleep apnea, snoring, restless leg syndrome, night terrors, sleepwalking, sleep paralysis and sleep-wake schedule disorders. Nearly 95 % of these disorders go undiagnosed and are never treated, jeopardizing the health of many people who are afflicted. Close to 80 % of people who are obese are at risk to sleep apnea. Untreated sleep apnea can increase the likelihood of critical medical consequences, such as irregular heartbeat, high blood pressure, heart failure, heart attack, and stroke. Sleep apnea is one of more than 80 sleep disorders and very few adults who are suffering from a sleep disorder seek medical attention.
Increasing evidence supports the hypothesis that sleep disturbances in patients with well-controlled asthma could be caused by obstructive sleep apnea (OSA).
According to Dr. Braido, it is likely that asthma complicates the treatment of OSA, or vice versa.”Rhinitis is a worsening factor for asthma and inflammation, and nasal congestion a risk factor for snoring. We know that snoring is strongly related to sleep apnea.”
In addition, Dr. Braido pointed out that,”Obesity is a predisposition for OSA development. The crucial question is how many of these patients suffered from sleep apnea. Anticholinergic treatments could be useful for patients with asthma and sleep apnea.”A diagnosis of OSA might be possible by monitoring levels of oral nitric oxide (NO), Dr. Braido advised. [Read Complee Post…. ]
Doctor Anderson with the Rocky Mountain Sleep Center says the most common sleep disorders are sleep apnea (most commonly known as airway obstruction,) insomnia and narcolepsy.
His discussion tonight focused on prevention and he says keeping weight gain to a minimum and practicing proper sleep hygiene will help. He adds that avoiding caffeine and maintaining an active lifestyle are beneficial.
“Number one, practice good sleep hygiene, regular sleep habits. If people have a problem getting to sleep, to not stay in bed later and get up at the same time and to start that early and practice good sleep hygiene. The second most important thing is to maintain an ideal weight,” says Dr. Anderson.
Fatigue and excessive daytime sleepiness (EDS) in idiopathic Parkinson’s disease (PD) correlate differently with motor symptoms, depression, and dopaminergic treatment, according to the results of a prospective study reported in the December 1 issue of the European Journal of Neurology.
“Sleep-wake disturbances including fatigue and …EDS are important non-motor features of idiopathic PD,” write P.O. Valko, from University Hospital of Zurich, Zurich, Switzerland, and colleagues. “EDS is present in up to 50–75% of patients with PD, thereby significantly surpassing the frequency of EDS in other brain disorders, e.g. multiple sclerosis, ischemic stroke, traumatic brain injury. …A comprehensive study of both fatigue and …EDS in association with …PD-related symptoms and treatment has not been performed yet.” Read the rest of this entry
A University of New Hampshire professor’s research into hospital bed technology could soon represent a giant leap forward in patient care.
John LaCourse, professor and chair of UNH’s Department of Electrical and Computer Engineering, is currently negotiating with hospital bed manufacturers to adopt his programmed algorithm technology, which could become the basis for “smart” computerized hospital beds. Read the rest of this entry
A potentially life-threatening challenge characterized by pauses in breathing that can last for more than 20 seconds, apnea of prematurity (AOP) affects more than 50% of premature infants and is almost universal in the smallest preemies. Caused in part by an underdeveloped central nervous system that can’t adequately regulate breathing outside of the womb, especially during sleep, AOP is not yet fully understood by scientists and remains a grave concern among neonatologists and parents alike.
New research published in the October issue of Pediatrics by clinical scientists at the University of Massachusetts Medical School suggests that heredity may play a strong role in determining an infant’s susceptibility to AOP and could lead to the development of more effective treatments and screening methods. Read the rest of this entry
Dr. David Anderson of the Rocky Mountain Sleep Disorders Center will give a presentation outlining sleep apnea and other serious sleep disorders Thursday, from 7 p.m. to 8 p.m. in the state room of the Red Lion Colonial Hotel. This is a free presentation to the public and refreshments will be served.
SleepApneaDisorder/ [ Press Release ]/ OKLAHOMA CITY / Graymark Healthcare, Inc. has closed the previously announced sale of substantially all the assets of its ApothecaryRx’s retail pharmacy business to Walgreens Co. ApothecaryRx operated 18 pharmacies across five states.
The transaction allows Graymark to focus on its core business of providing comprehensive care for sleep disorders, primarily obstructive sleep apnea, including diagnosis, therapy, and ongoing clinical and product support.
“Millions of Americans suffer from obstructive sleep apnea, and many aren’t aware they have a problem or that treatment is available in their communities,” said Stanton Nelson, chairman and CEO of Graymark Healthcare. “As a pure-play sleep disorders company focused primarily on obstructive sleep apnea, we believe Graymark is better able to help people sleep better.” Read the rest of this entry
U. Joseph Schoepf, M.D., of the Medical University of South Carolina in Charleston, and colleagues found that patients with obstructive sleep apnea (OSA) appear to have an increased risk of developing a more aggressive form of atherosclerosis. The investigators evaluated 49 obese patients (mean age, 61 years) with OSA and a mean body mass index (BMI) of 33 kg/m², and 46 obese patients without the condition (mean age of 60 years and mean BMI of 30 kg/m²), using coronary computed tomography angiography (cCTA).
The data revealed that patients with OSA had a significantly higher prevalence of non-calcified and mixed plaques compared to patients without the condition.
“cCTA is an effective way to noninvasively diagnose non-calcified and mixed plaque,” Schoepf said in a statement. “With technological advancements that are lowering the radiation dose required for cCTA, this exam could become a screening tool for obese individuals at increased risk for cardiovascular disease.”
Research and Markets has announced the addition of GlobalData’s new report “Europe Anesthesia and Respiratory Devices Market Outlook to 2016″ to their offering.
“Europe Anesthesia and Respiratory Devices Market Outlook to 2016″ provides key market data on the Europe Anesthesia and Respiratory Devices market United Kingdom, Germany, France, Italy and Spain. The report provides value (US$ million) data for all the market categories Airway Anesthesia Disposables, Anesthesia Machines, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices, Sleep Apnea Diagnostic Systems, Regional Anesthesia Disposables, and Pain Management Devices.
The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants and is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Globaldata’s team of industry experts.